SAN DIEGO--(BUSINESS WIRE)--Traditional approaches to developing drugs that target kinases rely on selecting a single kinase of interest and finding a compound that inhibits it, a time consuming and resource-intensive process. The new approach of high throughput kinase profiling gives drug developers a tool to make kinase-focused drug discovery more efficient and cost effective.
